Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jokelainen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Alcoholism, Clinical and Experimental Research|May 1, 1997
Characteristics of alcohol dehydrogenases of certain aerobic bacteria representing human colonic floraT Nosova, H Jousimies-Somer, P Kaihovaara, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1996
In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in manK Jokelainen, A Siitonen, H Jousimies-Somer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1996
Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestineT Nosova, K Jokelainen, P Kaihovaara, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 13, 1999
Ciprofloxacin administration decreases enhanced ethanol elimination in ethanol-fed ratsT Nosova, K Jokelainen, P Kaihovaara, et al.
Life Sciences|January 1, 1997
Inhibition of bacteriocolonic pathway for ethanol oxidation by ciprofloxacin in ratsK Jokelainen, T Nosova, T Koivisto, et al.
The American Journal of Cardiology|April 15, 1996
The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscleR Laaksonen, K Jokelainen, J Laakso, et al.
Endoscopy|October 31, 2012
Risk factors for complications of ERCP in primary sclerosing cholangitisS Ismail, L Kylänpää, H Mustonen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administrationA A Nanji, K Jokelainen, G K Lau, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the ratA A Nanji, K Jokelainen, A Rahemtulla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 14, 2001
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokinesA A Nanji, K Jokelainen, M Fotouhinia, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Alcoholism, Clinical and Experimental Research|May 1, 1997
Characteristics of alcohol dehydrogenases of certain aerobic bacteria representing human colonic floraT Nosova, H Jousimies-Somer, P Kaihovaara, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1996
In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in manK Jokelainen, A Siitonen, H Jousimies-Somer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 1, 1996
Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestineT Nosova, K Jokelainen, P Kaihovaara, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 13, 1999
Ciprofloxacin administration decreases enhanced ethanol elimination in ethanol-fed ratsT Nosova, K Jokelainen, P Kaihovaara, et al.
Life Sciences|January 1, 1997
Inhibition of bacteriocolonic pathway for ethanol oxidation by ciprofloxacin in ratsK Jokelainen, T Nosova, T Koivisto, et al.
The American Journal of Cardiology|April 15, 1996
The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscleR Laaksonen, K Jokelainen, J Laakso, et al.
Endoscopy|October 31, 2012
Risk factors for complications of ERCP in primary sclerosing cholangitisS Ismail, L Kylänpää, H Mustonen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administrationA A Nanji, K Jokelainen, G K Lau, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the ratA A Nanji, K Jokelainen, A Rahemtulla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 14, 2001
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokinesA A Nanji, K Jokelainen, M Fotouhinia, et al.
Pageof 4